FRAMINGHAM, Mass.--(BUSINESS WIRE)--Nov. 21, 2005--Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) will present at the following forum: What: Informed Investors Biotechnology & Healthcare Investor Forum in San Francisco When: December 7, 2005 @ 10:15 AM Pacific Standard Time. Sponsors: Barron’s, The Wall Street Journal and Business Wire. Keynote Presentations: John McCamant, Editor of The Medical Technology Stock Letter. Adam Noah, Ph.D., Vice President, Biotechnology Equity Research, Merriman Curhan Ford & Co.
